View ValuationOngwe Minerals 将来の成長Future 基準チェック /06現在、 Ongwe Mineralsの成長と収益を予測するのに十分なアナリストの調査がありません。主要情報n/a収益成長率n/aEPS成長率Metals and Mining 収益成長13.8%収益成長率n/a将来の株主資本利益率n/aアナリストカバレッジNone最終更新日n/a今後の成長に関する最新情報更新なしすべての更新を表示Recent updatesお知らせ • Jul 02Ongwe Minerals Inc. announced that it has received CAD 23.00092 million in fundingOn June 30, 2026, Ongwe Minerals Inc. has amended the terms and closed the transaction. The company will now issue 13,334,000 common shares of the Company at a price of CAD1.38 per Common Share for aggregate gross proceeds to the Company of CAD 18,400,920. This total included 2,174,000 Common Shares issued pursuant to the full exercise of the Agents' option and concurrent private placement and issued 3,333,333 Common Shares at the Issue Price for additional gross proceeds of CAD 4,600,000. The Company paid a cash commission equal to 6% of the gross proceeds of the LIFE Offering, subject to a reduced fee of 3% for sales up to CAD 3,000,000 to purchasers on a designated "President's List", and 1% for certain purchasers agreed upon between the Company and Beacon and 555,682 Broker Warrants to the Agents. Each Broker Warrant entitles the holder thereof to acquire a Common Share of the Company at a price of CAD1.38 per share, for a period of 24 months from the closing date. The Company paid Cirrus a finder's fee equal to 3% of the gross proceeds of the Private Placement. Additionally, Cirrus received up to 3% finder's fees on gross proceeds from certain purchasers in the LIFE Offering as agreed between the Company and Cirrus.お知らせ • Jun 13Ongwe Minerals Inc. announced that it expects to receive CAD 13.00086 million in fundingOngwe Minerals Inc. has entered into an agreement in connection with best efforts private placement (LIFE offering) to issue 7,247,000 common shares at a price of CAD 1.38 per common share for aggregate gross proceeds of CAD 10,000,860 and a concurrent non brokered private placement of 2,173,913 Common Shares at the issue price of CAD 1.38 per common share for aggregate gross proceeds of approximately CAD 2,999,999.94 for total aggregates of CAD 13,000,859.94 on June 11, 2026. The closing of the LIFE Offering is not conditional upon the closing of the Private Placement. The Company has agreed to pay to the Agents a cash fee of 6.0% of the gross proceeds of the LIFE Offering, and to issue to the Agents compensation options entitling the Agents to purchase a number of Common Shares equal to 6.0% of the Common Shares issued in connection with the LIFE offering at the issue price for a term of 24 months from the closing of the LIFE Offering. The LIFE Offering and Private Placement are expected to close on or about June 25, 2026. The transaction is subject to receiving all necessary regulatory approvals including the conditional approval of the TSX Venture Exchange. The Common Shares issued to Canadian subscribers pursuant to the LIFE Offering will not be subject to a hold period pursuant to applicable Canadian securities laws. The Common Shares issued in connection with the Private Placement will be subject to a statutory hold period ending four months and a day following the closing date. The Company anticipates certain insiders of the Company may participate in the LIFE Offering. Subject to compliance with applicable regulatory requirements and in accordance with National Instrument 45-106, Prospectus Exemptions, the common shares issuable under the LIFE offering will be offered for sale to purchasers resident in each of the provinces of Canada, other than Quebec, and/or other qualifying jurisdictions, pursuant to the listed issuer financing exemption under Part 5A of NI 45-106, as amended by Coordinated Blanket Order 45-935, Exemptions from Certain Conditions of the Listed Issuer Financing Exemption. The common shares issuable in connection with the private placement will be offered by way of private placement pursuant to applicable exemptions from prospectus requirements (other than in the listed issuer financing exemption) in each of the provinces of Canada and in such other jurisdictions outside of Canada and the United States provided it is understood that no prospectus filing or comparable obligation arises in such other jurisdiction. The Company has granted the Agents an option exercisable in whole or in part, at any time up to 48 hours prior to the Closing Date to purchase for resale up to an additional 1,087,000 Common Shares at the Issue Price for additional gross proceeds of up to CAD 1,500,060.お知らせ • Jun 10Ongwe Minerals Inc., Annual General Meeting, Aug 20, 2026Ongwe Minerals Inc., Annual General Meeting, Aug 20, 2026. このセクションでは通常、投資家が会社の利益創出能力を理解する一助となるよう、プロのアナリストのコンセンサス予想に基づく収益と利益の成長予測を提示する。しかし、Ongwe Minerals は十分な過去のデータを提供しておらず、アナリストの予測もないため、過去のデータを外挿したり、アナリストの予測を使用しても、その将来の収益を確実に算出することはできません。 シンプリー・ウォール・ストリートがカバーする企業の97%は過去の財務データを持っているため、これはかなり稀な状況です。 業績と収益の成長予測OTCPK:GQML.F - アナリストの将来予測と過去の財務データ ( )CAD Millions日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数3/31/2026N/A-11-4-4N/A12/31/2025N/A-3-3-3N/A9/30/2025N/A-3-1-1N/A6/30/2025N/A-4-2-2N/A3/31/2025N/A-4-2-2N/Aアナリストによる今後の成長予測収入対貯蓄率: GQML.Fの予測収益成長が 貯蓄率 ( 3.5% ) を上回っているかどうかを判断するにはデータが不十分です。収益対市場: GQML.Fの収益がUS市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です高成長収益: GQML.Fの収益が今後 3 年間で 大幅に 増加すると予想されるかどうかを判断するにはデータが不十分です。収益対市場: GQML.Fの収益がUS市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。高い収益成長: GQML.Fの収益が年間20%よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。一株当たり利益成長率予想将来の株主資本利益率将来のROE: GQML.Fの 自己資本利益率 が 3 年後に高くなると予測されるかどうかを判断するにはデータが不十分です成長企業の発掘7D1Y7D1Y7D1YMaterials 業界の高成長企業。View Past Performance企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/07/16 04:54終値2026/06/03 00:00収益2026/03/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレークこのレポートを生成するために使用した分析モデルの詳細は、当社のGitHubページでご覧いただけます。また、レポートの活用方法に関するガイドやYouTubeのチュートリアルも用意しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Ongwe Minerals Inc. 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
お知らせ • Jul 02Ongwe Minerals Inc. announced that it has received CAD 23.00092 million in fundingOn June 30, 2026, Ongwe Minerals Inc. has amended the terms and closed the transaction. The company will now issue 13,334,000 common shares of the Company at a price of CAD1.38 per Common Share for aggregate gross proceeds to the Company of CAD 18,400,920. This total included 2,174,000 Common Shares issued pursuant to the full exercise of the Agents' option and concurrent private placement and issued 3,333,333 Common Shares at the Issue Price for additional gross proceeds of CAD 4,600,000. The Company paid a cash commission equal to 6% of the gross proceeds of the LIFE Offering, subject to a reduced fee of 3% for sales up to CAD 3,000,000 to purchasers on a designated "President's List", and 1% for certain purchasers agreed upon between the Company and Beacon and 555,682 Broker Warrants to the Agents. Each Broker Warrant entitles the holder thereof to acquire a Common Share of the Company at a price of CAD1.38 per share, for a period of 24 months from the closing date. The Company paid Cirrus a finder's fee equal to 3% of the gross proceeds of the Private Placement. Additionally, Cirrus received up to 3% finder's fees on gross proceeds from certain purchasers in the LIFE Offering as agreed between the Company and Cirrus.
お知らせ • Jun 13Ongwe Minerals Inc. announced that it expects to receive CAD 13.00086 million in fundingOngwe Minerals Inc. has entered into an agreement in connection with best efforts private placement (LIFE offering) to issue 7,247,000 common shares at a price of CAD 1.38 per common share for aggregate gross proceeds of CAD 10,000,860 and a concurrent non brokered private placement of 2,173,913 Common Shares at the issue price of CAD 1.38 per common share for aggregate gross proceeds of approximately CAD 2,999,999.94 for total aggregates of CAD 13,000,859.94 on June 11, 2026. The closing of the LIFE Offering is not conditional upon the closing of the Private Placement. The Company has agreed to pay to the Agents a cash fee of 6.0% of the gross proceeds of the LIFE Offering, and to issue to the Agents compensation options entitling the Agents to purchase a number of Common Shares equal to 6.0% of the Common Shares issued in connection with the LIFE offering at the issue price for a term of 24 months from the closing of the LIFE Offering. The LIFE Offering and Private Placement are expected to close on or about June 25, 2026. The transaction is subject to receiving all necessary regulatory approvals including the conditional approval of the TSX Venture Exchange. The Common Shares issued to Canadian subscribers pursuant to the LIFE Offering will not be subject to a hold period pursuant to applicable Canadian securities laws. The Common Shares issued in connection with the Private Placement will be subject to a statutory hold period ending four months and a day following the closing date. The Company anticipates certain insiders of the Company may participate in the LIFE Offering. Subject to compliance with applicable regulatory requirements and in accordance with National Instrument 45-106, Prospectus Exemptions, the common shares issuable under the LIFE offering will be offered for sale to purchasers resident in each of the provinces of Canada, other than Quebec, and/or other qualifying jurisdictions, pursuant to the listed issuer financing exemption under Part 5A of NI 45-106, as amended by Coordinated Blanket Order 45-935, Exemptions from Certain Conditions of the Listed Issuer Financing Exemption. The common shares issuable in connection with the private placement will be offered by way of private placement pursuant to applicable exemptions from prospectus requirements (other than in the listed issuer financing exemption) in each of the provinces of Canada and in such other jurisdictions outside of Canada and the United States provided it is understood that no prospectus filing or comparable obligation arises in such other jurisdiction. The Company has granted the Agents an option exercisable in whole or in part, at any time up to 48 hours prior to the Closing Date to purchase for resale up to an additional 1,087,000 Common Shares at the Issue Price for additional gross proceeds of up to CAD 1,500,060.
お知らせ • Jun 10Ongwe Minerals Inc., Annual General Meeting, Aug 20, 2026Ongwe Minerals Inc., Annual General Meeting, Aug 20, 2026.